GemVax&KAEL Revenue

In the year 2024, GemVax&KAEL had annual revenue of 62.69B KRW, down -13.18%. GemVax&KAEL had revenue of 18.27B in the quarter ending December 31, 2024, a decrease of -0.22%.

Revenue

62.69B

Revenue Growth

-13.18%

P/S Ratio

20.03

Revenue / Employee

337.05M

Employees

186

Market Cap

1,257.85B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	62.69B	-9.52B	-13.18%
Dec 31, 2023	72.21B	-3.60B	-4.74%
Dec 31, 2022	75.80B	15.43B	25.56%
Dec 31, 2021	60.37B	-5.29B	-8.06%
Dec 31, 2020	65.66B	23.00B	53.91%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Electronics	300.87T
SK hynix	66.19T
LG Energy Solution	25.62T
Samsung Biologics	4,547.32B
Hyundai Motor Company	175.23T
Kia Corporation	107.45T
Celltrion	3,557.30B
KB Financial Group	15.01T

Revenue Rankings